Animal models in mycology.

[1]  M. Miyaji,et al.  Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. , 2002, Medical mycology.

[2]  T. Bertsch,et al.  Germ Tubes and Proteinase Activity Contribute to Virulence of Candida albicans in Murine Peritonitis , 1999, Infection and Immunity.

[3]  J. Latgé,et al.  Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants. , 1999, Microbial pathogenesis.

[4]  N. Cardona-Castro,et al.  Development of a chronic chromoblastomycosis model in immunocompetent mice. , 1999, Medical mycology.

[5]  R. Sobel,et al.  A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit. , 1998, The Journal of infectious diseases.

[6]  K. Yoshida.  [The correlation between tissue injury and calcium oxalate crystal production in rat's lung with experimental Aspergillus niger infection]. , 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[7]  M. Ghannoum,et al.  Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models , 1998, Antimicrobial Agents and Chemotherapy.

[8]  J. Smith,et al.  Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis , 1997, Antimicrobial agents and chemotherapy.

[9]  A. Chakrabarti,et al.  Rabbit as an animal model of paranasal sinus mycoses. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[10]  N. Cardona-Castro,et al.  Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole. , 1996, Memorias do Instituto Oswaldo Cruz.

[11]  N. Kudeken,et al.  Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[12]  D. Stevens,et al.  Experimental systemic cryptococcosis in SCID mice. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[13]  A. Niimi,et al.  Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection , 1996, Journal of clinical microbiology.

[14]  J. Sobel,et al.  A murine model of Candida glabrata vaginitis. , 1996, The Journal of infectious diseases.

[15]  D. Denning,et al.  Efficacy of oral saperconazole in systemic murine aspergillosis. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[16]  D. DeBoer,et al.  Inability of two topical treatments to influence the course of experimentally induced dermatophytosis in cats. , 1995, Journal of the American Veterinary Medical Association.

[17]  R. Allendoerfer,et al.  Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis , 1995, Infection and immunity.

[18]  C. Bouthet,et al.  Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice. , 1995, The Journal of antimicrobial chemotherapy.

[19]  E. Anaissie,et al.  Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis , 1994, Antimicrobial Agents and Chemotherapy.

[20]  R. Crichton,et al.  Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. , 1994, Kidney international.

[21]  S. Moser,et al.  Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia. , 1994, American journal of respiratory and critical care medicine.

[22]  M. Denis,et al.  Experimental Allergic Bronchopulmonary Aspergillosis in the Mouse: Immunological and Histological Features , 1994, Scandinavian journal of immunology.

[23]  M. Kaku,et al.  Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis , 1993, Antimicrobial Agents and Chemotherapy.

[24]  R. Coffman,et al.  Effect of anti‐IL‐4, interferon‐gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome , 1993, Clinical and experimental immunology.

[25]  R. Allendoerfer,et al.  Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. , 1993, The Journal of infectious diseases.

[26]  E. Brummer,et al.  IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304). , 1993, Cellular immunology.

[27]  Y. Schneider,et al.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. , 1993, The Journal of clinical investigation.

[28]  G. Lopez-Berestein,et al.  Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. , 1992, The Journal of infectious diseases.

[29]  Hongyung Choi,et al.  A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. , 1992, Journal of immunology.

[30]  J. Griswold,et al.  Intracranial complications of mucormycosis: An experimental model and clinical review , 1992, The Laryngoscope.

[31]  T. Walsh,et al.  Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  P. J. Szaniszlo,et al.  Melanized and non‐melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies , 1992, Mycoses.

[33]  J. Graybill,et al.  Immunohistopathology of murine pulmonary histoplasmosis during normal and hypersensitive conditions. , 1991, The American review of respiratory disease.

[34]  E. Rosenberg,et al.  Efficacy of Bimolane in the Malassezia ovalis Model of Psoriasis , 1991, The Journal of dermatology.

[35]  J. Bullock,et al.  Fungal endophthalmitis. An experimental study with a review of 17 human ocular cases. , 1991, Archives of ophthalmology.

[36]  D. Stevens,et al.  Synergy between cilofungin and amphotericin B in a murine model of candidiasis , 1991, Antimicrobial Agents and Chemotherapy.

[37]  D. Armstrong,et al.  Model of recurrent pulmonary aspergillosis in rats , 1991, Journal of clinical microbiology.

[38]  D. Denning,et al.  Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis , 1991, Antimicrobial Agents and Chemotherapy.

[39]  R. Greenfield,et al.  Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome , 1991, Infection and immunity.

[40]  J. V. van Cutsem,et al.  The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. , 1990, Journal of the American Academy of Dermatology.

[41]  B. Zimmer,et al.  Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis , 1990, Antimicrobial Agents and Chemotherapy.

[42]  A. Sugar,et al.  Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent , 1990, Antimicrobial Agents and Chemotherapy.

[43]  D. Stynen,et al.  Detection of Circulating Galactomannan by Pastorex Aspergillus in Experimental Invasive Aspergillosis , 1990, Mycoses.

[44]  J. Cohen,et al.  Invasive aspergillosis: clinical and pathological features of a new animal model. , 1989, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[45]  C. Mody,et al.  Treatment of murine cryptococcosis with cyclosporin-A in normal and athymic mice. , 1989, The American review of respiratory disease.

[46]  P. Kincade,et al.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome , 1988, Infection and immunity.

[47]  J. Bennett,et al.  Efficacies of four antifungal agents in experimental murine sporotrichosis , 1988, Antimicrobial Agents and Chemotherapy.

[48]  E. Brummer,et al.  Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice , 1988, Infection and immunity.

[49]  E. Brummer,et al.  Chronic pulmonary and disseminated paracoccidioidomycosis in mice: quantitation of progression and chronicity. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[50]  R. Blackstock,et al.  Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance , 1987, Infection and immunity.

[51]  G. R. Peters,et al.  Treatment of paracoccidioidomycosis with itraconazole in a murine model. , 1985, The Journal of tropical medicine and hygiene.

[52]  R. Galask,et al.  Influence of estrogen and normal flora on vaginal candidiasis in the rat. , 1984, The Journal of reproductive medicine.

[53]  R. Hay,et al.  Experimental dermatophytosis: the clinical and histopathologic features of a mouse model using Trichophyton quinckeanum (mouse favus). , 1983, The Journal of investigative dermatology.

[54]  C. Halde,et al.  Murine model of pulmonary mucormycosis in cortisone-treated mice. , 1982, Sabouraudia.

[55]  J. J. Ellis,et al.  Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among zygomycetes. , 1981, Sabouraudia.

[56]  É. Drouhet,et al.  Dermatite expérimentale à pityrosporum ovale et (ou) pityrosporum orbiculare chez le cobaye et la souris , 1980 .

[57]  R. Taylor,et al.  Experimental sporotrichosis in Syrian hamsters , 1979, Infection and immunity.

[58]  J. O. Morrison,et al.  Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. , 1977, The Journal of infectious diseases.

[59]  R. D. King,et al.  A quantitative dermatophyte infection model in the guinea pig--a parallel to the quantitated human infection model. , 1976, The Journal of investigative dermatology.

[60]  D. K. Sandhu,et al.  Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species. , 1970, Sabouraudia.